Cipralex



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Depression 22.2%
Panic Attack 22.2%
Analgesia 11.1%
Cerebral Ischaemia 5.6%
Endometriosis 5.6%
Gastrointestinal Disorder 5.6%
Herpes Simplex 5.6%
Hypertension 5.6%
Major Depression 5.6%
Postpartum Depression 5.6%
Sleep Disorder 5.6%
Hyponatraemia 22.2%
Convulsion 11.1%
Sexual Dysfunction 11.1%
Suicide Attempt 11.1%
Syncope 11.1%
Tremor 11.1%
Upper Gastrointestinal Haemorrhage 11.1%
Vertigo Positional 11.1%
Secondary
Product Used For Unknown Indication 32.5%
Depression 20.0%
Drug Use For Unknown Indication 16.1%
Anxiety 4.8%
Intentional Overdose 4.0%
Pain 3.3%
Schizoaffective Disorder 2.4%
Hypertension 2.4%
Parkinson's Disease 1.9%
Mental Disorder 1.8%
Osteoarthritis 1.8%
Schizophrenia 1.5%
Panic Disorder 1.2%
Breast Cancer 1.2%
Insomnia 1.0%
Thrombosis Prophylaxis 1.0%
Drug Exposure During Pregnancy 0.9%
Ill-defined Disorder 0.7%
Rheumatoid Arthritis 0.7%
Bipolar Disorder 0.7%
Intentional Overdose 18.8%
Sopor 8.1%
Vomiting 8.1%
Tachycardia 6.5%
Drug Exposure During Pregnancy 5.4%
Suicide Attempt 5.4%
Cerebral Haemorrhage 4.3%
Overdose 4.3%
Rhabdomyolysis 4.3%
Suicidal Ideation 3.8%
Torsade De Pointes 3.8%
Urinary Retention 3.8%
Withdrawal Syndrome 3.8%
Ecchymosis 3.2%
Somnolence 3.2%
Abortion Spontaneous 2.7%
Disturbance In Attention 2.7%
Electrocardiogram Qt Prolonged 2.7%
Intra-uterine Death 2.7%
Pregnancy 2.7%
Concomitant
Product Used For Unknown Indication 32.4%
Depression 14.1%
Drug Use For Unknown Indication 8.3%
Hypertension 6.3%
Pain 6.0%
Anxiety 4.0%
Crohn's Disease 3.6%
Rheumatoid Arthritis 3.6%
Prophylaxis 2.4%
Insomnia 2.2%
Multiple Sclerosis 2.0%
Parkinson's Disease 2.0%
Prostate Cancer 1.8%
Osteoporosis 1.8%
Breast Cancer 1.7%
Diabetes Mellitus 1.7%
Schizophrenia 1.7%
Nausea 1.6%
Constipation 1.5%
Hepatitis C 1.4%
Weight Increased 16.3%
Vomiting 9.7%
Suicidal Ideation 7.4%
Weight Decreased 6.4%
Pulmonary Embolism 5.4%
Urinary Tract Infection 5.2%
Syncope 5.0%
Tremor 5.0%
Visual Impairment 5.0%
Myocardial Infarction 4.2%
Suicide Attempt 4.2%
Withdrawal Syndrome 3.7%
Neutropenia 3.5%
Tachycardia 3.2%
Death 3.0%
Hepatic Encephalopathy 2.7%
Pneumonia 2.7%
Overdose 2.5%
Swelling Face 2.5%
Thrombosis 2.5%
Interacting
Depression 26.9%
Product Used For Unknown Indication 19.2%
Drug Use For Unknown Indication 14.3%
Urinary Tract Infection 4.4%
Anxiety 3.3%
Anxiety Disorder 3.3%
Bipolar Disorder 2.7%
Schizophrenia 2.7%
Anorexia Nervosa 2.2%
Back Pain 2.2%
Essential Hypertension 2.2%
Hallucination 2.2%
Migraine 2.2%
Renal Transplant 2.2%
Smoking Cessation Therapy 2.2%
Hypertension 1.6%
Insomnia 1.6%
Myocardial Ischaemia 1.6%
Schizoaffective Disorder Depressive Type 1.6%
Blood Pressure Increased 1.1%
Hyponatraemia 17.6%
Drug Interaction 7.8%
Supraventricular Extrasystoles 7.8%
Vomiting 7.8%
Psychotic Disorder 5.9%
Tremor 5.9%
Dyskinesia 3.9%
Extrapyramidal Disorder 3.9%
Lipodystrophy Acquired 3.9%
Liver Disorder 3.9%
Malaise 3.9%
Metabolic Syndrome 3.9%
Somnolence 3.9%
Suicidal Ideation 3.9%
Transaminases Increased 3.9%
Urinary Tract Infection 3.9%
Gait Disturbance 2.0%
Generalised Oedema 2.0%
Grand Mal Convulsion 2.0%
Hallucination, Visual 2.0%